Project profile — Equitable access to therapeutics



Overview 

CA-3-P009897001
$230,000,000
UNICEF - United Nations Children's Fund (41122)
2021-03-30 - 2024-12-31
Terminating
Global Affairs Canada
YFMInternaAssistPartnershp&Programing Br

Country / region 

• Europe, regional (5.00%)
• Africa, regional (45.00%)
• Asia, regional (40.00%)
• South America, regional (10.00%)

Sector 

• Health: COVID-19 control (12264) (100.00%)

Description 

This project supports the Access to COVID-19 Tools Accelerator (ACT-A). It aims to help ensure equitable access to COVID-19 therapeutics, including novel antivirals and medical oxygen in Low-Income Countries (LICs) and Lower-Middle Income Countries (LMICs). Project activities include: (1) coordinating the procurement and delivery of COVID-19 antivirals; and (2) coordinating the procurement, delivery, and installation of medical oxygen facilities and supplies.

Expected results 

The expected outcomes of this project include: (1) increased equitable procurement and delivery of COVID-19 therapeutics; and (2) increased access to medical oxygen facilities and supplies.

Results achieved 

The result achieved as of December 2023 through the support of the Canadian government and other international donors includes the provision of novel COVID-19 antivirals, medical oxygen facilities, and supplies to 74 countries.

Budget and spending 


Original budget $0
Planned disbursement $0
Transactions
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Bilateral
Type of aid Contributions to specific-purpose programmes and funds managed by implementing partners
Date modified: